Frequently Asked Questions

The Genentech Patient Foundation gives free Genentech medicine to people who don’t have insurance coverage or who have difficulty paying for their Genentech medicine.

Patients will get free Genentech medicine if they:

• Do not have insurance or coverage for their Genentech medicine and their household makes less than $150,000 per year
• Have insurance, can't afford their out-of-pocket costs, have pursued all available financial assistance and meet certain income requirements

Learn more about qualifying for the Genentech Patient Foundation.

A current list of the medications supported by the Genentech Patient Foundation can be found here.

Steps for enrolling into the Genentech Patient Foundation can be found here.

Call a Foundation Specialist at (888) 941-3331, Monday through Friday, 6 a.m.–5 p.m. PT.

Foundation Specialists are your main point of contact at the Genentech Patient Foundation. They are always ready to help walk you through your next steps. They have local knowledge and can tell you the best options for help in your area.

If you qualify based on the Genentech Patient Foundation criteria, you will get your Genentech medicine for free.

Learn more about qualifying for the Genentech Patient Foundation.

If you qualify based on the Genentech Patient Foundation criteria, you will get your Genentech medicine for free.

Learn more about qualifying for the Genentech Patient Foundation.

• The health insurance plan does not have the Genentech medicine on its list of covered medicines (also known as a “formulary”)
• The health insurance plan includes certain restrictions that limit the ability to receive the prescribed Genentech medicine. Genentech Access Solutions may be able to help explain the insurance plan’s policy

If your health insurance plan requires you to use another medicine before you can use a Genentech medicine (also known as a "step edit" or "step therapy"), you must follow your plan requirements before the Genentech Patient Foundation can help you. Certain exceptions apply. To learn more, please call a Foundation Specialist at (888) 941-3331, Monday through Friday, 6 a.m.–5 p.m. PT.

No. If your health insurance plan denied your coverage for your Genentech medicine, you can apply for help from the Genentech Patient Foundation. You do not need to send us proof of your appeal to get help.

We encourage all patients to consider other forms of financial assistance that may be available through Genentech Co Pay cards and/or co-pay assistance foundations prior to applying for support through the Genentech Patient Foundation.

How much the patient and his or her family currently makes each year.

Genentech has a few programs to help get our medicines to the people who need them. Genentech Access Solutions can help you understand your insurance coverage and may help with referring you to programs that can help you pay for your medicine.

If you meet the eligibility criteria for the Genentech Patient Foundation, you will be able to get your prescribed Genentech medicine for free.

Patients who are enrolled in the Genentech Patient Foundation will keep getting free medicine as long as they qualify. They do not need to re-enroll.

At Genentech, we believe that each patient should get the medicine their doctor prescribed. We work to get our medicines to those who need them. The Genentech Patient Foundation is just one of the ways we help people in need.

Learn more about how we help patients.

• Health care providers can order medicines by:

  • Calling a Foundation Specialist at (888) 941-3331
  • Using the Prescriber Foundation Form
  • Using the Product Replacement Form
  • Using the Upfront Shipment Request Form

  Learn more about the Genentech Patient Foundation logistics.

For additional information about available resources, please contact your Genentech Field Reimbursement Manager.

For the following medicines, health care providers may administer from existing stock to enrolled patients and then order replacement product:

• ACTEMRA^® (tocilizumab)
• ACTIVASE^® (alteplase)
• AVASTIN^® (bevacizumab)
• CATHFLO^® Activase (alteplase)
• GAZYVA^® (obinutuzumab)
• HERCEPTIN^® (trastuzumab)
• HERCEPTIN HYLECTA^® (trastuzumab and hyaluronidase-oysk)
• KADCYLA^® (ado-trastuzumab emtansine)
• LUCENTIS^® (ranibizumab injection)
• OCREVUS^® (ocrelizumab)
• PERJETA^® (pertuzumab)
• PEGASYS^® (peginterferon alfa-2a)
• POLIVY^TM (polatuzumab vedotin-piiq)
• RITUXAN^® (rituximab)
• RITUXAN HYCELA^® (rituximab/hyaluronidase human)
• TECENTRIQ^® (atezolizumab)
• TNKASE^® (tenecteplase)
• XOLAIR^® (omalizumab) for subcutaneous use)

We changed our name to show our commitment to helping patients and to make it easier to remember.

While a benefits investigation is not necessary to receive assistance, we do require that you are aware of and attest to the patient's coverage status prior to enrolling in the Foundation.

No, proof of appeal is not necessary to receive assistance. Do not submit additional paperwork with your patient's enrollment, as this may cause delays.

While it is preferred that the Prescriber Foundation Form and Patient Consent Form are sent together, we are still able to review the patient's eligibility if we receive them separately.